Skip to content
Sentebiolab Biotechnology logo — Let's synthesize life together...

Sentebiolab Biotechnology

Let's synthesize life together...

Founded 2011 Turkey Turkey 14 employees Biotechnology

General Information

Company Name Sentebiolab Biotechnology
Founded Year 2011
Location Turkey Turkey
Employees 14
Industries Biotechnology
Business Model B2B, D2C, B2D
Revenue Model Service Fee, Product Sales, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Sentebiolab Biotechnology. To contact Sentebiolab Biotechnology, visit sentebiolab.com.tr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sentebiolab Biotechnology compare?

A PDF of Sentebiolab Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sentebiolab Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sentebiolab Biotechnology

Sentebiolab Biotechnology, founded in 2011, is a promising player within the Biotechnology sector. Headquartered in Turkey, the company aims to synthesize life by delivering a range of comprehensive services and products.

With the slogan "Let's synthesize life together...", Sentebiolab Biotechnology focuses on providing high-quality primers and probes and offers expertise courtesy of its PhD-credentialed team. Their service offerings encompass gene synthesis, Sanger and next-generation sequencing, cloning, and phylogenetic analyses.

While the company has not publicly announced its latest funding round or investment partners, the depth of its technical expertise, combined with a decade-long presence in the market, positions it attractively for future investment opportunities. Investors looking to tap into the biotech industry may find Sentebiolab Biotechnology's integrated approach and experienced team compelling for long-term partnerships.

Business keywords: synthetic biology, oligonucleotide synthesis, primers and probes, gene synthesis, Sanger sequencing, next-generation sequencing, DNA sequencing, cloning, phylogenetic analysis, consulting services, DNA analysis, RNA analysis, protein analysis, expert scientific team

Services & Products

Oligonucleotides & Primers
DNA Probes
Synthetic Gene & Cloning
Coronavirus Diagnostic Test Kit
DNA Sequencing Services
Genetic Design and Optimization
Collaborative Synthetic Biology Applications

Target Customers

Biotechnology Researchers Academic Institutions Pharmaceutical Companies Healthcare Providers Diagnostic Laboratories

No funding data available for Sentebiolab Biotechnology yet.

Sentebiolab Biotechnology Alternatives & Competitors

View All Alternatives
Sentebiolab Biotechnology vs

Honoring the Science of Life

56 employees
Biotechnology, Life Sciences
Sentebiolab Biotechnology vs
Synbio Technologies
Synbio Technologies United States

Changing the world, one sequence at a time.

25 employees
Biotechnology, Health Care
Sentebiolab Biotechnology vs
DNA2.0 (now ATUM)
DNA2.0 (now ATUM) United States

This page is retired. You can find our new company page at www.linkedin.com/company/atum-bio

9 employees
Biotechnology

FAQ About Sentebiolab Biotechnology

Let's synthesize life together...
Sentebiolab Biotechnology was founded in 2011.
Sentebiolab Biotechnology is headquartered in Turkey.
Sentebiolab Biotechnology operates in Biotechnology. Its work centres on synthetic biology, oligonucleotide synthesis, primers and probes and gene synthesis. Its customers include Biotechnology Researchers, Academic Institutions and Pharmaceutical Companies.
Sentebiolab Biotechnology has a B2B, D2C and B2D business model. Its revenue comes from Service Fee, Product Sales and Consulting Fee.
Sentebiolab Biotechnology has approximately 14 employees.
Sentebiolab Biotechnology offers: Oligonucleotides & Primers, DNA Probes, Synthetic Gene & Cloning, Coronavirus Diagnostic Test Kit, DNA Sequencing Services, Genetic Design and Optimization, Collaborative Synthetic Biology Applications.
Top alternatives and competitors to Sentebiolab Biotechnology include Eurofins Genomics Americas, Synbio Technologies, DNA2.0 (now ATUM), New England Biolabs, Camena Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sentebiolab Biotechnology and Eurofins Genomics Americas are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sentebiolab Biotechnology, https://bouncewatch.com/company/sentebiolab, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout